TUDOR INVESTMENT CORP ET AL

Position in AMLX — Amylyx Pharmaceuticals, Inc.

CIK 923093 STAMFORD, CT

Position in AMLX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$435,542

+$164,926 QoQ

Shares Held

31,334

+39.9% QoQ

Ownership

0.028%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2022

12 quarters on record

Voting authority Sole 50.ToString("F0")% Shared 50.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

TUDOR INVESTMENT CORP ET AL holds $23,421,840 across 9 Drug Manufacturers - Specialty & Generic names. AMLX ranks #6 (1.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TEVA	Teva Pharmaceutical Industries Ltd	544,501	$16,400,370
2	VTRS	Viatris Inc	276,210	$3,731,597
3	LQDA	Liquidia Corp	40,263	$1,519,525
4	XERS	Xeris Biopharma Holdings, Inc.	107,414	$623,001
5	COLL	Collegium Pharmaceutical, Inc	13,956	$461,524
6	AMLX	Amylyx Pharmaceuticals, Inc. This page	31,334	$435,542
7	ORGO	Organogenesis Holdings Inc.	63,580	$150,684
8	BHC	Bausch Health Companies Inc.	11,800	$63,720

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$435,542	31,334	+39.9%	Shares	Defined	2026-05-15
2025-12-31	$270,616	22,402	+85.6%	Shares	Defined	2026-02-17
2025-06-30	$77,387	12,073	-63.9%	Shares	Defined	2025-08-14
2025-03-31	$118,335	33,428	-0.8%	Shares	Defined	2025-05-15
2024-12-31	$127,336	33,687	+164.1%	Shares	Defined	2025-02-14
2024-03-31	$36,218	12,753	-62.1%	Shares	Defined	2024-05-15
2023-12-31	$495,357	33,652	+23.0%	Shares	Defined	2024-02-14
2023-09-30	$500,943	27,359	-54.1%	Shares	Defined	2023-11-15
2023-06-30	$1,285,895	59,615	+58.7%	Shares	Defined	2023-08-14
2023-03-31	$1,102,127	37,564	+4.4%	Shares	Defined	2023-05-15
2022-12-31	$1,330,089	35,997	+123.1%	Shares	Defined	2023-02-14
2022-09-30	$454,284	16,138	—	Shares	Defined	2022-11-14
No filing history on record for this holder in this stock.